Prathiksha Giridharan

Prathiksha Giridharan

Auto-generated profile, based on publicly available information

Prathiksha Giridharan

ICMR- National Institute for Research in Tuberculosis, Chennai, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MMManoj Vasant Murhekar
Manoj Vasant Murhekar
TBTarun Bhatnagar
Tarun Bhatnagar
JTJeromie Wesley Vivian Thangaraj
Jeromie Wesley Vivian Thangaraj
VSV. Saravanakumar
V. Saravanakumar
MKMuthusamy Santhosh Kumar
Muthusamy Santhosh Kumar
AVArya Vinod
Arya Vinod
Earlier serosurveys in India revealed seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) of 0.73% in May–June 2020 and 7.1% in August–September 2020. A third serosurvey was conducted between December 2020 and January 2021 to estimate the seroprevalence of SARS-CoV-2 infection among the general population and healthcare workers (HCWs) in India. The third serosurvey was conducted in the same 70 districts as the first and second serosurveys. For each district, at least 400 individuals aged ≥10 years from the general population and 100 HCWs from subdistrict-level health facilities were enrolled. Serum samples from the general population were tested for the presence of immunoglobulin G (IgG) antibodies against the nucleocapsid (N) and spike (S1-RBD) proteins of SARS-CoV-2, whereas serum samples from HCWs were tested for anti-S1-RBD. Weighted seroprevalence adjusted for assay characteristics was estimated. Of the 28,598 serum samples from the general population, 4585 (16%) had IgG antibodies against the N protein, 6647 (23.2%) had IgG antibodies against the S1-RBD protein, and 7436 (26%) had IgG antibodies against either the N protein or the S1-RBD protein. Weighted and assay-characteristic-adjusted seroprevalence against either of the antibodies was 24.1% [95% confidence interval (CI) 23.0–25.3%]. Among 7385 HCWs, the seroprevalence of anti-S1-RBD IgG antibodies was 25.6% (95% CI 23.5–27.8%). Nearly one in four individuals aged ≥10 years from the general population as well as HCWs in India had been exposed to SARS-CoV-2 by December 2020.

21 December 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PGPrathiksha Giridharan
Prathiksha Giridharan
SSSriram Selvaraju
Sriram Selvaraju
RRRaghuram Rao
Raghuram Rao
KRKiran Rade
Kiran Rade
KTKannan Thiruvengadam
Kannan Thiruvengadam
BBBalram Bhargava
Balram Bhargava
Recurrent Tuberculosis patients contribute to a significant proportion of TB burden in India. A nationwide survey was conducted during 2019–2021 across India among adults to estimate the prevalence of TB. A total of 322480 individuals were screened and 1402 were having TB. Of this, 381 (27.1%) had recurrent TB. The crude prevalence (95% CI) of recurrent TB was 118 (107–131) per 100,000 population. The median duration between episodes of TB was 24 months. The proportion of drug resistant TB was 11.3% and 3.6% in the recurrent group and new TB patients respectively. Higher prevalence of recurrent TB was observed in elderly, males, malnourished, known diabetics, smokers, and alcohol users. (p<0.001). To prevent TB recurrence, all treated tuberculosis patients must be followed at least for 24 months, with screening for Chest X-ray, liquid culture every 6 months, smoking cessation, alcohol cessation, nutritional interventions and good diabetic management.

26 June 2024 in Public Health in Practice
Verified
Journal Article
Open access
PGPrathiksha Giridharan
Prathiksha Giridharan
RSRakesh P. Suseela
Rakesh P. Suseela
TZTandin Zangpo
Tandin Zangpo
RJRita Bhandari Joshi
Rita Bhandari Joshi
MCMizaya Cader
Mizaya Cader
CPChandrasekaran Padmapriyadarsini
Chandrasekaran Padmapriyadarsini
Countries in the South East Asian region face similar challenges in control of infectious diseases. There is limited access to experiences and learnings of neighboring countries. The Indian Council - of Medical Research (ICMR) has established a Regional Enabler for the South-East Asia Research Collaboration for Health (RESEARCH) Platform for South East Asian Region (SEAR) countries to address the above issues. This paper discusses about current practices, implementation challenges and operations research priorities of Tuberculosis Preventive therapy (TPT) in eight SEAR countries. A three day workshop on “Capacity Building for TB Research under Programmatic Settings”. was conducted under the aegis of this RESEARCH platform jointly ICMR and the Union which was participated by eight SEAR countries. Data were collected from a semi-structured questionnaire prior to the workshop and open discussions during the workshop. The various challenges faced for TPT implementation were broadly categorized as poor demand and low level of acceptance by the beneficiary, low level of acceptance to provide TPT among the providers, challenges in ruling out active TB, issues with supply and supply chain management of diagnostic tests and drugs. Many operations research priorities like person centric TPT driven models, capacity building for improving cascade of care for latent TB infection, health system strengthening and effective risk communication were identified. Full implementation of the TPT guidelines requires focused attention and coordinated action from all stakeholders of the country to attain the full benefit of TB preventive therapy and the ultimate TB elimination goal.

1 July 2020 in Indian Journal of Tuberculosis
Verified
Journal Article
Closed access
PGPrathiksha Giridharan
Prathiksha Giridharan
ESElilarasi Selladurai
Elilarasi Selladurai
SBSarath Balaji
Sarath Balaji
SPSnegha Karunakaran Pramila
Snegha Karunakaran Pramila
AVArunagirinathan V
Arunagirinathan V
BDBella Devaleenal Daniel
Bella Devaleenal Daniel

25 January 2024 in Global Health: Science and Practice
Verified
Journal Article
Open access
PDF file
PGPrathiksha Giridharan
Prathiksha Giridharan
HMHavenesh Murugesan
Havenesh Murugesan
SSSriram Selvaraju
Sriram Selvaraju
AFAsha Frederick
Asha Frederick
TST. S. Selvavinayagam
T. S. Selvavinayagam
PCPadmapriyadarsini Chandrasekeran
Padmapriyadarsini Chandrasekeran
Estimating the burden of TB at the subnational level is critical to planning and prioritizing resources for TB control activities according to the local epidemiological situation. We report the experiences and operational challenges of implementing a TB prevalence survey at the subnational level in India. Information was collected from research reports that gathered data from periodic meetings, informal discussions with study teams, letters of communication, and various site visit reports. During the implementation of the survey, several challenges were encountered, including frequent turnover in human resources, lack of survey participation and community engagement, breakdown of X-ray machines, laboratory issues that delayed sputum sample testing, delays in X-ray reading, and network and Internet connectivity issues that impeded data management. To help ensure the survey was implemented in a timely manner, we developed several solutions, including planning ahead to anticipate challenges, ensuring timely communication, having a high commitment from all stakeholders, having strong team motivation, providing repetitive hands-on training, and involving local leaders to increase community engagement. This experience may help future states and countries that plan to conduct TB prevalence surveys to address these anticipated challenges and develop alternative strategies well in advance. Key Findings The reliance on mobile X-ray vans, availability of radiographers to read X-rays, adequate facilities for collecting and transporting sputum, and sufficient laboratories to process the samples posed challenges to implementing the Tamil Nadu TB prevalence survey. Issues with Internet connectivity hindered data syncing. In some areas, low participation and lack of community engagement posed additional challenges. Adapting the survey to the convenience of the community, involving local leadership in the survey, and providing training on community engagement strategies increased participation. Key Implications Stakeholders can learn from this experience in conducting large-scale TB surveys in endemic settings within the framework of existing systems to plan ahead for potential challenges. Strong monitoring by an expert technical group during survey implementation can help identify and resolve operational challenges in a timely manner.

Verified
Journal Article
Open access
PDF file
MMMalaisamy Muniyandi
Malaisamy Muniyandi
KNKarikalan Nagarajan
Karikalan Nagarajan
KMKavi Mathiyazhagan
Kavi Mathiyazhagan
PGPrathiksha Giridharan
Prathiksha Giridharan
KTKannan Thiruvengadam
Kannan Thiruvengadam
RKRajendran Krishnan
Rajendran Krishnan
Objective: To estimate the prevalence and incidence of TB before and during the COVID-19 pandemic in Tamil Nadu, south India. Methods: In the present study, the effect of COVID-19 epidemiology on the TB epidemic was assessed by the SEIR (Susceptible-Exposed-Infected-Recovered), a compartmental epidemiological model. The model input parameters on compartments of TB and incidence of COVID-19 were collected from the published literature. Based on the data collected, point prevalence and incidence of TB per 100,000 population is calculated with and without COVID-19. A prediction was conducted up to 2025, trend analysis was performed, and a trend chi-square test and chi-square test of independence were used to test the difference between the prevalence with and without COVID-19. R software 2000 (R 4.0.0) was used for analysis. Results: The TB prevalence without and with COVID-19 decreases from 289 in 2020 to 271 in 2025 and from 289 in 2020 to 269 in 2025, respectively. Similarly, the incidence of TB was decreasing from 144 in 2020 to 135 in 2025 without COVID-19 and 143 in 2020 to 134 in 2025 with COVID-19. Though the TB burden is decreasing over the years, the trend was not statistically significant (p > 0.05). With respect to the district level, the prevalence and incidence of TB with and without COVID-19 is also found to be decreasing over the years. It was also found that the difference in the prevalence and incidence of TB with and without COVID-19 was not statically significant. Conclusion: The results of our study shows that there was an annual decline of around 2% from 2020 to 2025 in the trend of the prevalence and incidence of TB with and without COVID-19. Overall, there is a reduction, but it was not significant, and there is no significant effect of COVID-19 on TB in Tamil Nadu.